David Kerr

Q: What Schools Are Affiliated With David Kerr

David Kerr is affiliated with the following schools: University of Pennsylvania, University of Malawi, University of Strathclyde, Imperial College London, University of Oxford, University of Johannesburg, Durham University, University of Birmingham, University of Divinity, University of Siena, University of Glasgow, University of Barcelona

David Kerr 's AcademicInfluence.com Rankings

David Kerr

Medical

#1072

World Rank

#1368

Historical Rank

Oncology

#43

World Rank

#46

Historical Rank

medical Degrees

David Kerr

Philosophy

#4664

World Rank

#7264

Historical Rank

Logic

#2076

World Rank

#2982

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

David Kerr 's Degrees

PhD Oncology University of Oxford

Why Is David Kerr Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor David James Kerr CBE is a British Cancer Researcherer. His primary area of research is treatment and management of colorectal cancer. He served as Chief Research Advisor at Sidra Medical and Research Center in Doha, Qatar. David James Kerr is Professor of Cancer Medicine and Former Fellow of Corpus Christi College, Oxford. He was also President-Elect for European Society for Medical Oncology .

(See a Problem?)

David Kerr 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. (2004) (2432)
International network of cancer genome projects (2010) (1839)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. (2012) (1300)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. (2007) (1156)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial (2001) (998)
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 (2007) (838)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study (2020) (821)
Delivering affordable cancer care in high-income countries. (2011) (656)
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. (2004) (632)
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. (2011) (616)
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. (1996) (599)
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer (2008) (599)
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial (2001) (598)
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 (2008) (578)
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk (2007) (528)
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas (2013) (519)
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. (2011) (492)
Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas (2012) (487)
Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey (2000) (433)
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study (2020) (429)
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. (1999) (429)
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer (2009) (409)
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. (2002) (403)
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33 (2010) (391)
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. (2005) (387)
Genetic prognostic and predictive markers in colorectal cancer (2009) (384)
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. (2011) (349)
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer (2004) (342)
Genetic prognostic and predictive markers in colorectal cancer (2011) (333)
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk (2008) (320)
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. (1995) (315)
ICCS 2009 International Report: Civic knowledge, attitudes and engagement among lower secondary school students in thirty-eight countries. (2010) (300)
Predictive biomarkers: a paradigm shift towards personalized cancer medicine (2011) (274)
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma (2009) (271)
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. (2009) (263)
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. (1996) (257)
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. (2011) (249)
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk (2012) (234)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study (2020) (231)
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group. (1998) (231)
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial (2003) (226)
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. (1996) (223)
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. (2007) (223)
Clinical trials of P-glycoprotein reversal in solid tumours. (1996) (216)
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. (1996) (216)
Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial (2000) (213)
Multiple Common Susceptibility Variants near BMP Pathway Loci GREM1, BMP4, and BMP2 Explain Part of the Missing Heritability of Colorectal Cancer (2011) (204)
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. (2014) (198)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. (2016) (196)
KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer (2011) (194)
Arginine methylation controls growth regulation by E2F‐1 (2012) (188)
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. (2013) (184)
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial (2003) (183)
Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. (1992) (177)
International civic and citizenship education study : assessment framework (2008) (168)
Initial Findings from the IEA International Civic and Citizenship Education Study (2010) (166)
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials (2016) (165)
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. (1995) (163)
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial (2002) (160)
Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma. (2011) (160)
The epidemiology of thyroid carcinoma. (1993) (157)
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. (1999) (157)
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. (2000) (150)
Multidrug Resistance in Cancer (1989) (148)
Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway (2002) (141)
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. (1993) (141)
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy (2010) (138)
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group. (1995) (137)
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. (2001) (134)
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals (2012) (133)
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. (2007) (133)
Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) (132)
QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients. (2004) (131)
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations (2013) (131)
Citizenship education in England 2001-2010: young people’s practices and prospects for the future: the eighth and final report from the Citizenship Education Longitudinal Study (CELS). (2010) (130)
A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study. (2009) (129)
Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. (2001) (128)
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer. (2004) (127)
Anti-proliferative activity and mechanism of action of titanocene dichloride. (1998) (126)
Single-Dose Clinical Pharmacokinetic Studies of Gefitinib (2005) (126)
Open access chemical and clinical probes to support drug discovery. (2009) (122)
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. (2011) (121)
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene. (1997) (120)
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. (2009) (117)
Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group. (1998) (115)
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. (2016) (115)
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer (2015) (111)
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial (2009) (111)
Tobacco: deadly in any form or disguise (2006) (109)
Designing deep learning studies in cancer diagnostics (2021) (108)
NITROREDUCTASE: A PRODRUG‐ACTIVATING ENZYME FOR CANCER GENE THERAPY (2004) (107)
Adjuvant Therapy of Colorectal Cancer (2000) (106)
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. (2006) (104)
Importance of and approaches to incorporating ethics into the accounting classroom (1995) (103)
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial. (1994) (102)
The challenge of cancer control in Africa (2008) (101)
Citizenship Education Longitudinal Study: Second Cross-Sectional Survey, 2004. Listening to Young People: Citizenship Education in England. Research Report RR626. (2006) (100)
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres (2011) (99)
Fluorescence studies of the intra-cellular distribution of zinc bis(thiosemicarbazone) complexes in human cancer cells. (2005) (99)
Bevacizumab--current status and future directions. (2005) (99)
Colorectal cancer. (1999) (96)
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS (2014) (95)
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer. (1998) (94)
ICCS 2009 European Report: Civic Knowledge, Attitudes, and Engagement among Lower-Secondary Students in 24 European Countries. (2010) (94)
Standard operating procedure for the collection of fresh frozen tissue samples. (2007) (93)
Clinical development of gene therapy for colorectal cancer (2003) (92)
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. (2006) (92)
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. (2010) (90)
Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. (1992) (89)
New directions in the treatment of colorectal cancer: a look to the future. (2000) (88)
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial. (1985) (88)
Changing the Political Culture: the Advisory Group on Education for Citizenship and the Teaching of Democracy in Schools (1999) (88)
Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. (2001) (85)
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance (2019) (84)
Targeting angiogenesis in cancer: clinical development of bevacizumab (2004) (84)
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer (2013) (84)
The new Eurasianism: The rise of geopolitics in Russia's foreign policy (1995) (82)
Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. (1991) (82)
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council. (1996) (82)
Phase I and pharmacokinetic study of flavone acetic acid. (1987) (81)
Cancer in patients receiving dialysis. (1980) (80)
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. (1999) (80)
Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. (1989) (80)
Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey (2000) (79)
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. (2005) (77)
Flavone acetic acid--preclinical and clinical activity. (1989) (75)
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. (2006) (74)
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. (2008) (73)
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. (2011) (72)
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis (2017) (72)
Citizenship Education in England: The Making of a New Subject (2003) (71)
Implications of polygenic risk for personalised colorectal cancer screening. (2016) (71)
Can we treat cancer for a dollar a day? Guidelines for low-income countries. (2010) (71)
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1 q 41 , 3 q 26 . 2 , 12 q 13 . 13 and 20 q 13 (2010) (70)
Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by non-small cell lung tumor cells in culture and its relationship to cell survival. (1986) (69)
Building capacity for sustainable research programmes for cancer in Africa (2014) (68)
Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer (2017) (68)
Redesigning cancer care (2002) (68)
Active Citizenship and Young People: Opportunities, Experiences and Challenges in and beyond School Citizenship Education Longitudinal Study: Fourth Annual Report. Research Report RR732. (2006) (68)
Virus-directed enzyme prodrug therapy using CB1954. (1999) (67)
Capecitabine: have we got the dose right? (2009) (66)
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. (1988) (65)
Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial. (1984) (65)
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 (2017) (64)
Long-term sequelae of treatment for testicular germ cell tumours. (1990) (64)
A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer. (1990) (64)
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. (2008) (63)
Alternative splicing of TIA‐1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance (2014) (62)
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. (2007) (62)
Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. (2011) (61)
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954 (2000) (61)
The effect of verapamil on the pharmacokinetics of adriamycin (2004) (60)
Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells. (1996) (59)
Identification of FGF receptor-binding peptides for cancer gene therapy (2002) (59)
Glass yttrium-90 microspheres for patients with colorectal liver metastases. (1992) (57)
Chromatin organisation and cancer prognosis: a pan-cancer study (2018) (57)
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). (2002) (57)
The TERT variant rs2736100 is associated with colorectal cancer risk (2012) (57)
Systemic treatment of colorectal cancer. (2002) (56)
Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells (2002) (56)
Embedding Citizenship Education (CE) in Secondary Schools in England (2002-2008) : Citizenship Education Longitudinal Study (CELS): Seventh Annual Report. (2009) (55)
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors. (2001) (53)
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN (2012) (53)
Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. (1999) (52)
Phase I and pharmacokinetic study of D-verapamil and doxorubicin. (1991) (52)
Aspects of cytotoxic drug penetration, with particular reference to anthracyclines (2004) (52)
Phase I trials of poly(I,C) complexes in advanced cancer. (1985) (51)
ABC of colorectal cancer (2011) (51)
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. (1988) (51)
Neural network and regression predictions of 5‐year survival after colon carcinoma treatment (2001) (51)
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group. (2000) (51)
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan. (2007) (50)
Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. (1993) (50)
New Molecular Targets for Cancer Chemotherapy (1994) (50)
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer (2016) (49)
CB 1954: from the Walker tumor to NQO2 and VDEPT. (2003) (49)
Hepatic arterial chemotherapy for metastatic colorectal carcinoma. (1994) (49)
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series (2018) (49)
Prognostic factors in thyroid tumours. (1986) (48)
African Popular Theatre: From Pre-Colonial Times to the Present Day (1995) (47)
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector (2004) (46)
Prognostic markers for colorectal cancer: estimating ploidy and stroma (2017) (46)
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor. (1988) (46)
Vision versus pragmatism : citizenship in the secondary school curriculum in England. Citizenship Education Longitudinal Study : fifth annual report (2007) (45)
Regional chemotherapy for colorectal liver metastases: A phase II evaluation of targeted hepatic arterial 5‐fluorouracil for colorectal liver metastases (1990) (45)
Strengthening clinical cancer research in the United Kingdom (2011) (44)
European Study Group for Pancreatic Cancer‐1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (44)
Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). (2008) (44)
Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution. (1991) (44)
TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview. (2006) (44)
England's results from the IEA International Citizenship Education Study : what citizenship and education mean to 14 year olds (2002) (43)
Gene therapy strategies for colon cancer. (2000) (43)
Novel treatments for hepatocellular cancer. (2009) (43)
The challenge of cancer control in Africa (2008) (43)
Pharmacokinetic principles of locoregional chemotherapy. (1993) (43)
Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer (2017) (43)
Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. (1995) (42)
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. (1997) (42)
WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs) (2005) (40)
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester). (1986) (39)
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. (2003) (39)
EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme (2012) (39)
Identification of oligopeptides binding to peritoneal tumors of gastric cancer (2006) (39)
Central Asian and Russian perspectives on China's strategic emergence (2010) (39)
Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft. (1988) (38)
Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. (2009) (38)
Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil? (1999) (38)
The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells (1999) (38)
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. (1991) (37)
Cytotoxic drug penetration studies in multicellular tumour spheroids. (1988) (37)
Adjuvant chemotherapy for stage II colorectal cancer: the time is right! (2005) (37)
Variability in the pharmacokinetics of epirubicin: a population analysis (2004) (37)
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars (2020) (36)
FIRST-LINE TEST OF THYROID FUNCTION (1984) (36)
Challenges of cancer control in developing countries: current status and future perspective. (2011) (36)
Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution. (1996) (36)
Cytotoxic‐loaded albumin microspheres: A novel approach to regional chemotherapy (1988) (35)
Academic Freedom and the University of Malawi (2002) (35)
A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (pts) with metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH pts. (2006) (35)
CHINA, XINJIANG, AND THE TRANSNATIONAL SECURITY OF CENTRAL ASIA (2008) (35)
Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease (2016) (35)
The Sino-Russian Partnership and U.S. Policy Toward North Korea: From Hegemony to Concert in Northeast Asia (2005) (35)
A pilot study of combination therapy with interferon-alpha-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours. (1996) (35)
Evolution of nonsurgical therapy for colorectal cancer (2009) (35)
Inequalities in breast cancer care and outcome. (1997) (34)
Ras as a target in cancer therapy. (2002) (34)
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. (1995) (34)
Citizenship Education in England, Ireland and Northern Ireland (2002) (34)
Final study summary and policy recommendations: participatory citizenship in the European Union (2012) (33)
The response of breast cancer cells to steroid and peptide growth factors. (1992) (33)
Clinical cancer research: the past, present and the future (2014) (33)
Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage (2019) (33)
Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study. (2008) (32)
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee. (1990) (32)
Making sense of citizenship : a continuing professional development handbook (2006) (32)
Conventional cytotoxic and novel therapeutic concepts in colorectal cancer (2001) (31)
Citizenship Through Secondary History (2001) (31)
Roles of tetrahydrobiopterin in promoting tumor angiogenesis. (2010) (31)
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. (2013) (31)
Establishing a national tissue bank for surgically harvested cancer tissue (2004) (30)
Pharmacoproteomic characterisation of human colon and rectal cancer (2017) (30)
Challenges and solutions in patient treatment strategies for stage II colon cancer (2019) (30)
The International Politics of EU-China Relations (2008) (30)
Use of a Phage Display Library to Identify Oligopeptides Binding to the Lumenal Surface of Polarized Endothelium by Ex Vivo Perfusion of Human Umbilical Veins (2003) (30)
TuBaFrost 6: virtual microscopy in virtual tumour banking. (2006) (30)
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma. (1998) (29)
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features (2019) (29)
Participatory popular theatre: the highest stage of cultural underdevelopment. (1991) (29)
Biomarkers in Early-Stage Colorectal Cancer: Ready for Prime Time? (2012) (29)
Comprehensive assessment of variation at the transforming growth factor β type 1 receptor locus and colorectal cancer predisposition (2010) (29)
Now the New Year reviving old desires. (2006) (29)
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database. (2016) (29)
'Toxgnostics': an unmet need in cancer medicine (2014) (29)
8. An international review of citizenship in the curriculum: the tea national case studies and the inca archive (2002) (28)
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. (1994) (28)
5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment? (1989) (28)
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom. (1997) (28)
Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future (2007) (27)
Drug metabolism in carcinogenesis and cancer chemotherapy. (1991) (27)
Defective mismatch repair in colon cancer: a prognostic or predictive biomarker? (2010) (27)
Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver. (2010) (27)
A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. (1997) (27)
TuBaFrost 5: multifunctional central database application for a European tumor bank. (2006) (27)
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma. (1992) (27)
Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. (1994) (27)
Genome‐wide association study and meta‐analysis in Northern European populations replicate multiple colorectal cancer risk loci (2017) (26)
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. (1991) (26)
A BRIEF HISTORY OF CANCER CHEMOTHERAPY (2002) (26)
A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma. (1997) (25)
Anticancer drug development (2002) (25)
The myelotoxicity of carboplatin is influenced by the time of its administration (1990) (25)
All-European Study on Policies for Education for Democratic Citizenship (EDC). (2004) (24)
Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration (1988) (24)
A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases. (1994) (24)
A two-phase case–control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22 (2011) (24)
Neural networks in the prediction of survival in patients with colorectal cancer. (2003) (24)
TuBaFrost 4: access rules and incentives for a European tumour bank. (2006) (23)
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? (1996) (23)
Citizenship Education in the United Kingdom (2008) (23)
In vitro chemosensitivity testing using the multicellular tumor spheroid model. (1987) (22)
Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13 (2011) (22)
Need for global action for cancer control. (2008) (22)
Etoposide protein binding in cancer patients (2004) (22)
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival (2015) (22)
Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. (1985) (22)
Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06 (2000) (22)
Gene expression in oestrogen-dependent human breast cancer xenograft tumours. (1990) (22)
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. (1987) (21)
IS THE TRH TEST USUALLY UNNECESSARY? (1984) (21)
The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids. (1986) (21)
CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC): preliminary results of a phase I/II study (2001) (21)
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. (1987) (21)
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer (1999) (21)
Chemotherapy for colorectal cancer (2000) (21)
Advanced colorectal cancer: which regimes should we recommend? (1999) (20)
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice. (1989) (20)
Comparative Study on the Clinicopathological Profiles of Breast Cancer Among Iraqi and British Patients (2018) (20)
Intratumoral stromal morphometry predicts disease recurrence but not response to 5‐fluorouracil—results from the QUASAR trial of colorectal cancer (2018) (20)
Adjuvant therapy (2000) (20)
Citizenship: Local, National and International (2003) (20)
Didactic Theatre in Africa (1981) (20)
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme. (1992) (20)
A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution. (2003) (20)
Access to Cancer Treatment in Low- and Middle-Income Countries - An Essential Part of Global Cancer Control (2010) (19)
Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusion. (1992) (19)
Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues. (1987) (19)
Innovative treatment for colon cancer (2000) (19)
VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION (2008) (19)
No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix. (1992) (18)
Phase I clinical trials: adapting methodology to face new challenges. (1994) (18)
The cytostatic effects of alpha-interferon may be mediated by transforming growth factor-beta. (1989) (18)
Multidrug resistance: clinical relevance in haematological malignancies. (1991) (18)
A trial of adjuvant therapy in colorectal cancer: the VICTOR trial. (2003) (18)
The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. (1990) (18)
A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid. (1992) (18)
Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. (1999) (17)
Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003 (2004) (17)
Hitler and the peasants : agrarian policy of the Third Reich, 1930-1939 (1992) (17)
Pupil Assessment in Citizenship Education: Purposes, Practices and Possibilities. : Report of a CIDREE Collaborative Project. (2009) (17)
Is sidedness prognostically important across all stages of colorectal cancer? (2016) (17)
Virtual microscopy in virtual tumor banking. (2006) (17)
Clinical experience with adenovirus in cancer therapy. (2002) (17)
Melphalan in Isolated Limb Perfusion for Malignant Melanoma, Bolus or Divided Dose, Tissue Levels, the pH Effect (1990) (17)
Has China abandoned self-reliance? (2007) (17)
Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusion. (1987) (17)
Serum and peritoneal dialysate thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis. (1986) (17)
Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV) (2005) (17)
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene. (1998) (16)
How much does liver disease affect the pharmacokinetics of adriamycin? (1985) (16)
The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum. (1985) (16)
Comparison of molecular and pathologic features of stage II and stage III colon cancer in four large studies conducted for development of the 12-gene colon cancer recurrence score. (2010) (16)
Intra-hepatic arterial drug delivery. (1996) (16)
Adjuvant therapy for pancreatic cancer (1995) (16)
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systems. (1987) (16)
Clinical efficacy of 'Tomudex' (raltitrexed) in advanced colorectal cancer (1997) (16)
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management (2021) (16)
How Useful Are International Treatment Guidelines in Low- and Middle-Income Countries? (2017) (15)
Tracing the trends and transitions in young people's citizenship practices: what are the implications for researching citizenship and citizenship education? (2011) (15)
An economic comparison of the net clinical benefit and treatment costs of raltitrexed and 5-fluorouracil + leucovorin (Mayo regimen) in advanced colorectal cancer (1999) (15)
The isolation and identification of cis-diamminedichloroplatinum (ii)-DNA adducts by anion-exchange HPLC and inductively coupled plasma mass-spectrometry. (1993) (14)
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients (2011) (14)
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. (2000) (14)
Appendix B: ECRI Evidence Report: Patients' Reasons for Participation in Clinical Trials and Effect of Trial Participation on Patient Outcomes (2006) (14)
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†. (2015) (14)
Inhibition of NF-κB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy (2005) (14)
Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg (1998) (14)
Quinone Oxidoreductase-2–Mediated Prodrug Cancer Therapy (2010) (14)
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer. (1995) (14)
Mitomycin C‐loaded microcapsules in the treatment of colorectal liver metastases. Pharmacokinetics of regionally administered particulate chemotherapy (1991) (14)
Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581). (2004) (14)
Microparticulate drug delivery systems as an adjunct to cancer treatment. (1987) (14)
Contextual analysis report: participatory citizenship in the European Union Institute of Education (2012) (14)
Citizenship education: an international comparison across sixteen countries (2002) (14)
Research-intensive cancer care in the NHS in the UK. (2011) (14)
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer (2018) (13)
Home delivery: chemotherapy and pizza? (2001) (13)
A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results. (2001) (13)
Addressing unwarranted variations in colorectal cancer outcomes: a conceptual approach (2016) (13)
Problems in Sino-Russian Economic Relations (1998) (13)
Quantitative analysis of vascular endothelial growth factor expression in chronic lymphocytic leukaemia. (1996) (13)
Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors? (2004) (12)
Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial. (2015) (12)
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer (2015) (12)
Do we bear any moral responsibility for improving cancer care in Africa? (2006) (12)
The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction. (1998) (12)
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). (2020) (12)
Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials. (2002) (12)
Phase III trial of adjuvant immunotherapy with MOAb 17–1A following resection for stage II adenocarcinoma of the colon (CALGB 9581) (2004) (12)
The value of additional bevacizumab in patients with high‐risk stroma‐high colon cancer. A study within the QUASAR2 trial, an open‐label randomized phase 3 trial (2018) (12)
Stage II colon cancer. (2013) (12)
Adjuvant treatment of colorectal cancer. (1997) (12)
Continuous vs intermittant chemotherapy for advanced colorectal cancer: preliminary results of the MRC cr06b randomised trial (2001) (12)
Opening and Closing the Sino-Russian Border: Trade, Regional Development and Political Interest in North-east Asia (1996) (12)
Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer (2013) (11)
Comparative and international perspectives on citizenship education (2011) (11)
Putting participation into practice: Re-evaluating the implementation of the citizenship curriculum in England (2013) (11)
Successful use of cisplatin to treat metastatic seminoma during cisplatin‐induced acute renal failure (1991) (11)
H-ras infection in mink lung epithelial cells may induce "atypical" multidrug resistance. (1991) (11)
Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985. (1988) (11)
Capecitabine/irinotecan combination regimens in colorectal cancer. (2002) (11)
Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer (2012) (11)
Immunotherapy for colorectal cancer: a challenge to clinical trial design. (2000) (11)
Hepatocellular carcinoma. (2001) (11)
Spontaneous pneumothorax associated with expectoration of a lump of metastatic renal cancer. (1997) (11)
Community theatre and public health in Malawi (1989) (11)
Clinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals (2006) (11)
Theatre and Social Issues in Malawi: Performers, Audiences, Aesthetics (1988) (10)
Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicity. (1982) (10)
A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases. (1992) (10)
First-line chemotherapy (2011) (10)
Flavone acetic acid: a nonlinear pharmacokinetic model (2004) (10)
The effect of transfection with the oncogenes H-ras and c-myc on the radiosensitivity of a mink epithelial cell line. (1992) (10)
Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequences. (1991) (10)
A comparison of regional and systemic chemotherapy for hepatic metastases. (1990) (10)
Young people’s civic attitudes and practices: England’s outcomes from the IEA International Civic and Citizenship Education Study (ICCS) (2010) (10)
Chemoembolism in cancer chemotherapy. (1991) (10)
Europe, China and security governance: is there evidence of normative convergence? (2014) (10)
Induction of the c-myc but not the cH-ras promoter by platinum compounds. (1995) (10)
Antimetabolites in Cancer Therapy (2008) (9)
Strategic support for decision makers. Policy tool for education for democratic citizenship and human rights (2010) (9)
Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour. (1991) (9)
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayers. (1988) (9)
Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia (2017) (9)
Gene therapy for colorectal cancer: therapeutic potential. (2001) (9)
The nitroreductase/CB1954 enzyme-prodrug system. (2004) (9)
TuBaFrost: European virtual tumor tissue banking. (2006) (9)
Evaluation of PIK 3 CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer (2018) (9)
Targeted therapies: Bevacizumab—has it reached its final resting place? (2011) (9)
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2022) (8)
The TERT variant rs 2736100 is associated with colorectal cancer risk (2015) (8)
From the margins to the mainstream: making and remaking an alternative music economy in Dar es Salaam (2018) (8)
Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? (2004) (8)
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis (2016) (8)
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands (2007) (8)
African film and literature: adapting violence to the screen (2010) (8)
Policy: EU data protection regulation—harming cancer research (2014) (7)
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what? (2005) (7)
Stage II colon cancer (2013) (7)
Is there a relationship between regional microsphere distribution and hepatic arterial blood flow? (1992) (7)
The Oncology Data Network (ODN): A Collaborative European Data‐Sharing Platform to Inform Cancer Care (2019) (7)
Identification of an Oligopeptide Binding to Hepatocellular Carcinoma (2007) (7)
Greater China and East Asian integration: Regionalism and rivalry (2004) (7)
Oxford Textbook of Cancer Biology (2019) (7)
Taking Gene Therapy into the Clinic (2003) (7)
Dilemmas of the ‘Middle Continent’: Russian Strategy for Eastern Eurasia (2009) (7)
EFFECTIVE ACCOUNTING INSTRUCTION: A COMPARISON OF INSTRUCTOR PRACTICES AND STUDENT PERSPECTIVES (2003) (7)
‘Underground’ rap performance, informality and cultural production in Dar es Salaam (2015) (7)
Citizenship and the economic crisis in Europe: An introduction (2016) (7)
Young people's civic attitudes and practices: England's outcomes from the IEA international civic and citizenship education study (ICCS) RR060 (2010) (7)
Analytic report: participatory citizenship in the European Union Institute of Education (2012) (7)
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer (2017) (7)
An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities (2021) (7)
LBA12FINAL RESULTS FROM QUASAR2, A MULTICENTRE, INTERNATIONAL RANDOMISED PHASE III TRIAL OF CAPECITABINE (CAP) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT SETTING OF STAGE II/III COLORECTAL CANCER (CRC) (2014) (7)
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer? (2008) (7)
NTRAC pioneering a virtual model. (2003) (7)
Can we individualise chemotherapy for colorectal cancer (2004) (7)
Variation in the availability of cancer drug generics in the United States of America. (2013) (7)
Colorectal cancer (1999) (6)
The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy. (2001) (6)
Ethics of Applied Theatre (2009) (6)
Delivering cancer care: a model from the West Midlands. (1996) (6)
Carboplatin as opposed to cisplatin does not stimulate the expression of the human immunodeficiency virus long terminal repeat sequences. (1992) (6)
A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastases. (1991) (6)
The Chinese and Russian Energy Sectors: Comparative Change and Potential Interaction (1999) (6)
Tumours of the diffuse endocrine system. (1987) (6)
African theatre: Southern Africa. (2004) (6)
An in vivo assessment of adriamycin-loaded albumin microspheres. (1992) (6)
Virus-directed enzyme prodrug therapy (VDEPT): A clinical trial of adenovirus-delivered nitroreductase (NTR) in combination with CB1954 in patients with primary or secondary liver cancer (2005) (6)
The Best of Both Worlds? Colonial Film Policy and Practice in Northern Rhodesia and Nyasaland (1993) (5)
The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cells. (1991) (5)
Intercultural, citizenship and human rights education: the challenges of implementation for policy, practice and research (2011) (5)
Pharmacokinetic considerations in the use of anticancer drugs during pregnancy: challenges and new developments (2015) (5)
A feasibility study of roquinimex (Linomide) and alpha interferon in patients with advanced malignant melanoma or renal carcinoma. (1998) (5)
The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells. (1991) (5)
Targeted therapies: Cetuximab plus chemotherapy in patients with advanced NSCLC (2009) (5)
A little citadel of light in a malignant sea of darkness. (2004) (5)
Performing the self : rappers, urban space and identity in Dar es Salaam (2014) (5)
DIVERGENCE BETWEEN MORTALITY AND INCIDENCE RATES OF THYROID CANCER IN SCOTLAND (1985) (5)
QUASAR Results: The Prognostic Validity of a Colon Cancer Recurrence Score and the Role of Multigene Profiles in Determining Risk (2010) (5)
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy. (2005) (5)
Teaching approaches that build resilience to extremism among young people (2011) (5)
African Theories of African Theatre (1996) (5)
Are NSAIDs Coming Back to Colorectal Cancer Therapy or Not? (2014) (5)
Biological markers: Tailoring treatment and trials to prognosis (2013) (5)
Immunotherapy for colorectal cancer: potential application in an adjuvant setting. (2000) (5)
701 ‘Tomudex’ (ZD1694) has a higher response rate, significantly less leucopenia and mucositis and a simpler dosing regimen than 5-fluorouracil (5-FU) and leucovorin (LV) for advanced colorectal cancer (CRC): First results of a phase III study (1995) (5)
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridin. (1997) (5)
On Not Becoming a Folklorist: Field Methodology and the Reproduction of Underdevelopment (1991) (5)
Intravenous (IV) vs intrahepatic arterial (IHA) 5fu/leucovorin for colorectal (CRC) liver metastases: preliminary results of the mrc cr05/eortc 40972 randomised trial (2001) (5)
Chronic non-communicable diseases, the European Chronic Disease Alliance--and cancer. (2011) (5)
Colorectal Cancer: A Multidisciplinary Approach (2012) (5)
Gene Profiling in Early Stage Disease (2010) (5)
The costs of managing advanced colorectal cancer: a broad perspective (1997) (5)
Colorectal Cancer: A Multidisciplinary Approach (2012) (5)
Bioassay of transforming growth factor-beta activity in acidic protein extracts from primary breast cancer specimens. (1993) (5)
Facing the Global Challenges of Access to Cancer Medication (2018) (5)
Predictive and prognostic value of gender in early-stage colon cancer: A pooled analysis of 33,345 patients from the ACCENT database. (2011) (4)
‘Folklore’, cultural property and modernisation in sub-Saharan Africa (2006) (4)
ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (4)
Peer mediation: citizenship and social inclusion revisited (2009) (4)
Strategies for Sustainable Cancer Care. (2016) (4)
Per ardua ad astra (2002) (4)
Immunotherapy for Gastrointestinal Cancer. (2017) (4)
A pilot study of a feasibility and economic analysis of home based chemotherapy in advanced colorectal cancer (1999) (4)
Germline mutations in the proofreading domains of POLE and POLD 1 predispose to colorectal adenomas and carcinomas (4)
Contribution of academic research to discovery and development of medicines: current status and future opportunities (2005) (4)
Celecoxib for Stage III Colon Cancer. (2021) (4)
Evaluating the Impact of Citizenship Education in Schools (2012) (4)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer (1998) (4)
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer (2015) (4)
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs. (1992) (4)
ATTRIBUTES AND TECHNIQUES OF HIGHLY EFFECTIVE ACCOUNTING EDUCATORS: A MULTINATIONAL STUDY (2003) (4)
QUASAR: a UKCCCR study of adjuvant chemotherapy (CT) for colorectal cancer (1999) (4)
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease (1989) (4)
An experiment in popular theatre in Malawi: the University Travelling Theatre to Mbalachanda, July, 1981 (1982) (4)
Towards post-genomic investigation of colorectal cancer (2000) (4)
Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (2009) (4)
Publication and Dissemination of Research Findings (2016) (4)
Relationship between the pharmacokinetics and toxicity of mitozolomide (2004) (4)
Genetic and immunological therapy for cancer (2000) (4)
Immunotherapy for colorectal cancer (2003) (4)
Curbing tobacco's toll starts with the professionals: World No Tobacco Day (2005) (3)
Regional chemotherapy : theory and practice (2000) (3)
Prognostic markers for colorectal cancer (2018) (3)
The emergence of ‘omics for the management of colorectal cancer (2011) (3)
Priorities for Civic and Citizenship Education in Europe (2011) (3)
Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse. (1993) (3)
Virus-directed enzyme prodrug therapy using retrovirally delivered E. coli nitroreductase and CB1954 (1998) (3)
ABC of colorectal cancer: The role of primary care (2001) (3)
Gene Therapy for Colorectal Cancer (2002) (3)
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer (2019) (3)
Genome‐wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer (2021) (3)
Space and Southern African Community Theatre—Real, Mediated and Symbolic (2007) (3)
Survival following stage II/III colon cancer (CC): Accent-based comparison versus matched general population (MGP). (2014) (3)
An evaluation of the clinical utility of a panel of variants in DPYD and ENOSF1 for predicting common capecitabine related toxicities. (2018) (3)
Should We Adapt Existing Quality Systems for Use in Low- and Middle-Income Countries? (2015) (3)
Moving beyond developmental paradigms: A case study and analysis of a TfD workshop in Bangladesh (2009) (3)
The reception of Nigerian video drama in a multicultural female community in Botswana (2011) (3)
The Oncology Data Network (ODN): Methodology, Challenges and Achievements. (2020) (3)
Why Don't Immune Checkpoint Inhibitors Work in Colorectal Cancer? (2017) (3)
N.B. La Thangue, L.R. Bandara (eds). Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (2002) (3)
Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer (2008) (3)
Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought. (2013) (3)
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study. (2022) (3)
Pride and judgement: the Annals of Oncology prizes. (2002) (3)
Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans (2004) (3)
Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers (2018) (3)
Tumour-infiltrating CD8+ lymphocytes as a prognostic marker in colorectal cancer: A retrospective, pooled analysis of the QUASAR2 and VICTOR trials. (2018) (3)
Gene therapy for colorectal cancer (2003) (3)
Chinese relations with the Russian Far East. (2001) (3)
The Effect of H-ras and C-myc Oncogene Transfection on the Response of Lung Epithelial Cells to Growth Factors and Cytotoxic Drugs (1991) (3)
Concordia res parvae crescent. (2006) (3)
A new model for cancer research in France (2006) (3)
Clinical Trials Explained (2006) (3)
Adjuvant chemotherapy for colorectal cancer. (1996) (3)
Stromal composition predicts recurrence of early rectal cancer after local excision (2021) (3)
Personalising cancer medicine with prognostic markers (2021) (2)
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study (2019) (2)
Can we individualize chemotherapy for colorectal cancer? (2004) (2)
A Phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients (2005) (2)
Can primary osteosarcoma act as a third space after high-dose methotrexate? (1991) (2)
Experiments in sound: generating sonic landscapes in online spaces (2020) (2)
Cytotoxic drug targetting to lung cancer cells in vitro with a complex of low density lipoprotein ldl daunomycin (1987) (2)
African Broadcasting Pioneers and the Origins of Radio Drama at Central African Broadcasting Services (1995) (2)
DCA, connecting with citizenship education : a mapping study : a mapping study to establish the links between citizenship education and the DCA's priorities under the Dca 5-Year Strategy (2005) (2)
Mechanisms of resistance to platinum chemotherapeutic agents (1995) (2)
Africa in Stereo: modernism, music and pan-African solidarity (2019) (2)
Questions About Clinical Trials: A Framework For Discussion (2006) (2)
Conclusion: How Close is China to National Rejuvenation? (2015) (2)
EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. (2005) (2)
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer. (1994) (2)
Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide) intravenously (IV) every 3 weeks (2008) (2)
Prognosis prediction of stage II colon cancer by gene expression profiling (2007) (2)
The Malipenga mime of Likoma Island (1983) (2)
How to Prioritize Cancer Care for Countries in Transition (2016) (2)
An historic shift in policy, or a blind leap of faith: the work of the citizenship Advisory Group in England (2002) (2)
A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC) (2002) (2)
Recruitment into studies assessing optimum duration of treatment must continue (1996) (2)
Between regionalism and world order : five structural factors in China-Europe relations to 2025. (2007) (2)
Principles of chemotherapy (2019) (2)
Chronobiologic quantification of nocturnal low-dose dopamine effect on circadian rhythms of thyroid-related hormones and prolactin (PRL). (1986) (2)
Methodological studies (2021) (2)
A word in your ear: the 2004 Annals of Oncology prizes (2004) (2)
Gene therapy for gastrointestinal cancer (1996) (2)
Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer (2021) (2)
Loss of expression of ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN (2012) (2)
The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo. (1991) (2)
Cancer - Identifying and overcoming resistance to treatment - Editorial overview (2006) (2)
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer (2020) (2)
Oncogene transfection of mink lung cells: effect on growth characteristics in vitro and in vivo. (1991) (2)
Gastrointestinal oncology: Evidence and analysis (2007) (2)
Strategies for Sustainable Cancer Care. (2016) (2)
Aspects of cytotoxic drug penetration (1987) (2)
W.B. Coleman & G.J. Tsongalis (eds). The Molecular Basis of Human Cancer (2002) (2)
Methodological aspects of phase-I studies of novel anticancer agents (review). (1992) (2)
Cancer in Africa: supporting advocates to stop the runaway train. (2013) (1)
Toxgnostics: predicting and preventing chemotherapy-induced side effects. (2014) (1)
Variability in the pharmacokinetics of epirubucin: a population analysis (1)
Survival and quality of life (QoL) of patients in ESPAC-1: A european, randomised study of assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (1)
Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499)) (2011) (1)
A Pyrrhic victory (2002) (1)
Deep learning and cancer biomarkers: recognising lead-time bias – Authors' reply (2021) (1)
Introduction: China’s Many Dreams (2015) (1)
"I'm afraid of it": a drama for AIDS awareness project in Botswana (1997) (1)
Better value cancer care for the 21st century. (2011) (1)
Biodun Jeyifo, The Yoruba Popular Travelling Theatre of Nigeria (1990) (1)
The challenge of cancer control in Africa (vol 8, pg 398, 2008) (2008) (1)
One hundred years of Christian-Muslim relations: with reference to the challenge of theological education in Africa (2003) (1)
Giving Voice to the Silent War: An Essay Review of Simuka Zimbabwe! by Zambuko/Izibuko (1996) (1)
Ambulatory infusion pumps for intra hepatic arterial chemotherapy (1993) (1)
The effect of 5-fluorouracil on rat adrenal function (1986) (1)
Novel therapeutic strategies for colorectal cancer. (1998) (1)
KISS: the 2006 Annals of Oncology prizes (2006) (1)
A national cancer plan for the UK. (2000) (1)
Comparative Regionalism: The Logic of Governance in Europe and East Asia (2007) (1)
O-016A prognostic marker for colorectal cancer: combining analyses of ploidy and stroma (2016) (1)
Young people’s civicattitudes and practices:England’s outcomes fromthe IEA InternationalCivic and CitizenshipEducation Study (ICCS) - Research Report DFE-RR060 (2010) (1)
Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story? (2008) (1)
Citizenship education and the teaching and learning of history (2003) (1)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. (1998) (1)
Unmasking the Spirits: Theatre in Malawi (1987) (1)
Targeted therapies: Manufacturer sponsorship bias in economic analyses matters (2012) (1)
Ideology, resistance and the transformation of performance traditions in post-colonial Malawi (1993) (1)
A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL) (2019) (1)
CHAPTER 20 – MECHANISTIC APPROACHES TO PHASE I CLINICAL TRIALS (2002) (1)
Connecting the Global Cancer Community (2015) (1)
Participation under the Spotlight: Defining Future Directions. Key Players Workshop, November 2007. Report and Action Plan. (2007) (1)
China’s Many Dreams (2015) (1)
'Maisha yetu ya kila siku kama vile movie': Fantasy, desire and urban space in Tanzanian music videos (2019) (1)
The Idea of Divine Hardening (1973) (1)
Pharmacokinetics ofcis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (iproplatinum, chip) in patients with normal and impaired renal function and following intraperitoneal administration (1988) (1)
M. Ponz de Leon (ed). Colorectal cancer (2003) (1)
Gastrointestinal tumors, colorectal (2012) (1)
Missiological developments from Edinburgh 1910 to Today (2008) (1)
Six of the Best, Upper GI 14 (2009) (1)
Women's health research at NIEHS. (1993) (1)
New approaches for the treatment of colorectal cancer in the adjuvant setting (2004) (1)
HIV Communication. Global Emergencies, Media Templates, and African Communities (A Personal Journey) (2013) (1)
Drama as a Form of Action Research (1997) (1)
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials Committee. (1992) (1)
EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme (2012) (1)
Mechanisms of cytotoxic drug resistance in breast cancer (1996) (1)
Determinants of anemia in cancer patients receiving chemotherapy (2004) (1)
What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting? (2009) (1)
Theatre in Malawi (1991) (1)
China and inner Asia : new frontiers and new challenges. (2012) (1)
Participatory citizenship in Europe: The effects of the economic crisis on policy, practice and citizen engagement across EU member states (2013) (1)
Occurrence of circulating 7-deoxyaglycone metabolites of 4′-deoxydoxorubicin in man (2004) (1)
Small bowel fistula secondary to endarteritis obliterans, complicating chemotherapy for small bowel lymphoma. (1992) (1)
Why Don’t Immune Checkpoint Inhibitors Work in Colorectal Cancer? (2017) (1)
Overview and Purpose of This Guide to Clinical Trials in the NHS (2006) (1)
Human quinone oxidoreductase 2 (NQO2) in complex with the cytostatic prodrug CB1954 (2005) (1)
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial (2022) (1)
Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine. (2019) (1)
What prospects for a “new kind of great power relations” between China and America? (2013) (1)
Clinical science and care incorporating the development of a European Platform for Clinical Research in Diabetes (EPCRD) (2010) (1)
Subject Index Vol. 58, 1997 (2004) (0)
Abstract 3200: Spliced variant of T-cell intercellular antigen 1 (TIA-1) in colorectal cancer. (2013) (0)
Clinical Trial Approval, Regulation and Funding (2006) (0)
L.B. Saltz (ed). Colorectal Cancer: Multimodality Management (2003) (0)
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY). (2019) (0)
Cumulative impact of 10 common genetic variants on colorectal cancer risk in 42,333 individuals from eight populations (2013) (0)
561PImproving treatment decisions in colon cancer: The tumor-stroma ratio (TSR) additional to the TNM classification (2017) (0)
Chapter 4.1 – Methodological Studies (2015) (0)
Determinants of anemia in cancer patients receiving chemotherapy. (2004) (0)
Somatic Mutations of Beta2-Microglobulin are Correlated with a Lack of Disease Recurrence in a Subset of Stage II Mismatch Repair Deficient Colorectal Cancers from the QUASAR Trial (2018) (0)
Socioeconomic Factors, Urological Epidemiology and Practice Patterns Re: Delivering Affordable Cancer Care in High-Income Countries (2011) (0)
Explorer A new GWAS and meta-analysis with 1000 Genomes imputation identifies novel risk variants for colorectal cancer (2017) (0)
Chapter 3.7.2 – Biomarkers in Oncology (2015) (0)
Effect of SNP haplotypes associated with colorectal cancer risk on outcome (2008) (0)
Talk of the Towns (1998) (0)
Hepatic artery chemotherapy and colorectal liver metastases. Authors' reply (2003) (0)
Incorporation of mitomycin-c (MMC) into ethylcellulose microcapsules: Evaluation of a phase I study in patients with liver metastases (1992) (0)
Feasibility of whole genome association study to find SNPs predictive of colorectal cancer outcome (2008) (0)
K. N. Syrigos, K. Harrington (eds). Targeted Therapy for Cancer (2003) (0)
Artificial neural network prediction of 5-year survival from colon cancer (1999) (0)
Changing paradigms in anticancer drug development: inhibiting angiogenesis in colorectal cancer (2009) (0)
Ketamine in the Management of Cancer Pain (2013) (0)
The evaluation of loading-doses of Medroxypregesterone acetate (MPA) with two different maintenance schedules in advanced breast cancer (1993) (0)
Roles of Tetrahydrobiopterin in Promoting Tumor (2010) (0)
STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS (2010) (0)
Prognostic factors inthyroid tumours (1986) (0)
Chapter 1 – Absorption and distribution of anticancer drugs (1993) (0)
The multicellular organism and cancer (2019) (0)
Special considerations of DMCs for oncology studies. (2017) (0)
A phase I trial to assess the safety, PK and PD of CXD101 in advanced cancer expressing the biomarker HR23B (2016) (0)
Crying wolf on drug safety (1982) (0)
Chromatin instability as a marker of poor prognosis for a range of malignancies. (2016) (0)
Phase IB study of methoxymorpholinodoxorubicin (PNU 152243; FCE 23762) administered in a 3 or 4 weekly schedule (1997) (0)
The calman report on cancer services (1995) (0)
PP 104 Stroma production within the primary tumor correlates with poor survival for stage I-II colon cancer patients (2011) (0)
Comprar Gastrointestinal Oncology: A Critical Multidisciplinary Approach | Yuman Fong | 9781405127837 | Blackwell Publishing (2008) (0)
ABSTRACTS OF THE BRITISH NUCLEAR MEDICINE SOCIETY AUTUMN MEETING 1987: The effect of intra-arterial angiotensin II (A II) on arteriovenous shunting in patients with liver metastases of colorectal origin (1988) (0)
ESPAC Satellite Symposium (1997) (0)
PHARMACOKINETIC ANALYSIS AND CLINICAL RESULTS OF THE PHASE 1 DOSE ESCALATION AND EXPANSION CXD101 TRIAL IN RELAPSED, REFRACTORY LYMPHOMA (2017) (0)
The Entente Cordiale—natural and necessary (2004) (0)
Virtual Oncology in the Time of COVID-19 Pandemic: Moving Forward! (2020) (0)
1768P Genome-wide association study to identify genetic markers predictive of early-onset capecitabine-induced toxicity (2021) (0)
Comprar ABC Of Colorectal Cancer | A. Young | 9781405177634 | Wiley (2011) (0)
CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL (2012) (0)
Original Paper 'Tomudex' (ZD1694): Results ofa Randomised Trial in Advanced Colorectal Cancer Demonstrate Efficacy and Reduced Mucositis and Leucopenia (1995) (0)
The Influence of Activin on the Tumor Microenvironment in Colon Cancer Metastasis (2022) (0)
Anemia and neutropenia in cancer patients receiving chemotherapy (2004) (0)
OP-JNCI180073 1400..1408 (2018) (0)
127 Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients (2009) (0)
Subject Index Vol. 30, Suppl. 2, 2012 (2012) (0)
Gene Therapy for Cancer: Prospects for the Treatment of Lung Tumours (1999) (0)
Fraud in science (1983) (0)
The Fall of Blood Pressure in Untreated Hypertensive Patients in Hospital is Due to a Decreasing Alarm Reaction (1982) (0)
Prognostic value of chronic inflammatory cell infiltrates in Duke's stage B and C colorectal cancer. (2010) (0)
Beyond the Clinic: Future Challenges for Therapy (1997) (0)
principles of traslational science-chapter (2010) (0)
28. Dynamic PET of intra-hepatic arterially infused 18F-5-fluorouracil (1997) (0)
Assay result variability during determination of mismatch repair deficiency status using immunohistochemistry: A transatlantic comparative study. (2011) (0)
Survival in Hodgkin's Disease Effect of Epstein-Barr Virus Infection on Response to Chemotherapy and (2013) (0)
EXPERIMENTAL INDUCED HYPOGLYCEAMIA (1996) (0)
Contents, Vol. 58, 1997 (1997) (0)
A randomised, double-blind, phase II study of three different marimastat schedules administered to patients with resected Dukes C colorectal cancer (2003) (0)
Intra-arterial 5-fluorouracil modulated by folinic acid for colorectal liver metastases (1996) (0)
RANDOMIZED TRIAL OF THREE CHEMOTHERAPY REGIMENS FOR ADVANCED COLORECTAL CANCER (2002) (0)
An international multidisciplinary approach to the management of advanced colorectal cancer (First of two parts) (Reprinted from Eur J Surg Oncol, vol 23, Suppl A, August 1997) (1998) (0)
Multidrug resistance in haematological malignancies (1990) (0)
Hepatic arterial chemotherapy: still on trial. (2000) (0)
Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis? (2006) (0)
Malignant peritoneal mesothelioma. Is there a new treatment? (2009) (0)
Mature results from the 'Tomudex' (raltitrexed) comparative study in advanced colorectal cancer (ACC) (1997) (0)
Today's Science, Tomorrow's Patient: the Pivotal Role of Tissue, Clinical Data and Informatics in Modern Drug Development (2006) (0)
Phase I trial of LM985 (1985) (0)
A PHASE I TOXICITY, DOSE FINDING AND PRELIMINARY EFFICACY ASSESSMENT OF LIPOTEICHOIC ACID-T FOR PLEURODESIS IN MALIGNANT PLEURAL EFFUSION (2008) (0)
Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment (2008) (0)
Conclusions: Cancer biology, a moveable feast (2019) (0)
Myelofibrosis associated with metastatic seminoma: a case report. (1992) (0)
Comprar Neurologic Examination | David Kerr | 9781405130295 | Wiley (2009) (0)
Early Clinical Trial Design: Methodological Studies (2015) (0)
The activity of MMP-2 is increased in human colorectal cancer (1998) (0)
Environmental Justice Leaders Meet (1995) (0)
Personalized medicine in colorectal cancer: the evidence so far (2012) (0)
SI: two years on (1977) (0)
Cancer Pathogenesis & Therapy: a New Journal, a New Inspiration (2022) (0)
Evidence that intracellular phosphatidate may regulate breast cancer cell invasion and metastasis. (1996) (0)
256 Dendritic cell vaccination for hepatocellular carcinoma (2003) (0)
Comprar Gastrointestinal Oncology: Evidence and Analysis | Peter McCulloch | 9780849398650 | Informa Healthcare (2007) (0)
Cost of treating colorectal cancers (1999) (0)
Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in Europe. (1997) (0)
Pseudohyperkalaemia. (1985) (0)
Theeffect ofadriamycin and4-deoxydoxorubicin (1986) (0)
Mismatch Repair Testing in Colorectal Cancer - Is Less More? (2012) (0)
Poster presentations (2012) (0)
Designing deep learning studies in cancer diagnostics (2021) (0)
Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage (2019) (0)
The Role of the Oncologist in the Treatment of Colorectal Cancer (2005) (0)
A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma (2004) (0)
Cancer of the Colon and Rectum: Treatment: Chemotherapy (2009) (0)
Anemia and neutropenia in cancer patients receiving chemotherapy. (2004) (0)
Oncogene Expression and Cervical Cancer (1991) (0)
Invited papers - Clinical Trial Updates Session (2000) (0)
Results of a Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CXD101: Preliminary Safety and Activity in Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma Patients (2016) (0)
ES5-3: Novel Approaches to Breast Cancer Management in Low-Income Countries. (2011) (0)
Understanding Clinical Trial Design and Results (2006) (0)
THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS (2012) (0)
Abstract B013: Activin’s influence on the tumor microenvironment in colon cancer (2022) (0)
35 Final results and survival data of a large International Trial confirm palliative benefits of ‘TOMUDEX’ (Raltitrexed) in advanced colorectal cancer (ACC) (1996) (0)
Molecular Chemotherapy Approaches (2005) (0)
MICROENCAPSULATION OF MITOMYCIN‐C WITH ETHYLCELLULOSE. DISSOLUTION STUDIES AND PHARMACOKINETICS IN PATIENTS WITH LIVER METASTASES (1990) (0)
74. The phospholipase D signal transduction pathway is up-regulated in multidrug resistant breast cancer cells (1995) (0)
Laboratory of Biochemical Risk Analysis (1993) (0)
A randomised assessment of interferon 2a (IFN) as a modulator of 5-fluorouracil and leucovorin in advanced colorectal cancer (1994) (0)
Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort (2002) (0)
Abstract 811: Stroma production within the primary tumor correlates with poor survival for stage I-II colon cancer patients (2010) (0)
PHASE-1 TRIAL OF GR63178A (1989) (0)
Motivation for primary health care in Machinga District. (1987) (0)
Modern chemotherapy for gynaecological cancer. Part 1: models, mechanisms and methods (1994) (0)
Revivalism in Britain: Review of the 17th to early 20th Centuries; with a Concluding Comparison with the 1907 Pyeng Yang Awakening (2006) (0)
Academic Freedom and the University (2016) (0)
The curriculum. (1973) (0)
Civil Society and China’s Governance Dilemmas in the Era of National Rejuvenation (2015) (0)
358Early results of a large randomised trial of ‘tomudex’ (raltitrexed) versus 5-fluorouracil (5FU) plus high dose leucovorin (HDLV) in patients with advanced colorectal cancer (ACC) (1996) (0)
China, Central Asia and Insurgent Islam (2006) (0)
Character Role, Madness, God, Biography, Narrative: Dismantling and Reassembling Bessie Head's 'A Question of Power' (1999) (0)
Local and Global Citizenship in the UK (2008) (0)
Teaching in Times of Changing Administrations and Stringent Budgets (2014) (0)
Christian dialogue with Islam: the challenge of political theology from the global South (2008) (0)
Worship and Festivals (2019) (0)
The postcolonial politics of post-national citizenship in Portugal (2017) (0)
Taking or Avoiding the Path to China-us Rivalry: European Perspectives and Responses (2016) (0)
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as ﬁrst-line therapy for advanced colorectal cancer (2005) (0)
Mission and Ecumenical Studies at Lund University (2006) (0)
David Kerr.qxd (2000) (0)
World Christianity and Inter-Religious Relations: Missionsvetenskap med Ekumenik. Toward a Definition of Mission Studies (2013) (0)
We need renewed political commitment to citizenship education and ongoing monitoring of its provision in schools (2014) (0)
Ex-post evaluation of the Europe for Citizens Programme 2007-2013 Final report (2015) (0)
Cell Based Therapy: Modified Cancer Cells (2017) (0)
Citizenship Education Longitudinal Study: Literature Review-Citizenship Education One Year On – What Does it Mean?: Emerging Definitions and Approaches in the First Year of National Curriculum Citizenship in England (2004) (0)
Sexual Abuse and Gender Conflict: The Experience of a Play Creation Process at the University of Botswana (2000) (0)
C. Ripamonti, E. Bruera (eds). Gastrointestinal Symptoms in Advanced Cancer Patients (2003) (0)
Thugs and Gangsters: Imagination and the practice of rapping in Dar es Salaam (2017) (0)
PIK3CA Mutation is Strongly Associated with K-ras 12/13 Mutation in Stage II/III Colorectal Cancer (2012) (0)
A change in the political culture » . Citizenship education in England (2019) (0)
’Edinburgh 1910’ to ’Edinburgh 2010’: questions in focus (2007) (0)
BIODEGRADABLE SYSTEMS FOR SUSTAINEDDELIVERY FODRUGS TO BRAIN- TOMORS (1995) (0)
Women as Artists in Contemporary Zimbabwe, and: Theatre, Performance and New Media in Africa (review) (2009) (0)
Middleton Mediated Prodrug Cancer Therapy − Quinone Oxidoreductase-2 (2010) (0)
Long-term sequelae oftreatment fortesticular germcell tumours (1990) (0)
CONSIDERATIONS IN THE DEVELOPMENT AND VALIDATION OF GENOMIC TESTS FOR CANCER RECURRENCE AND TREATMENT BENEFIT (2010) (0)
REVIEW: Images of Yesteryear: Filmmaking in Central Africa, by Louis Nell. (2002) (0)
“Commercium in Spiritualibis”: A Response to Samuel Schlorff (1983) (0)
A VISION IN A DANCE: Negotiating History And Myth Through Theatre (1999) (0)
Book Review: New Creative Community: The Art of Cultural Development (2008) (0)
The English School and Asia-Pacific Security (2007) (0)
Personal Encounters with Muslims and Their Faith (1976) (0)
Women as Artists in Contemporary Zimbabwe, by Kerstin Bolzt, andTheatre, Performance and New Media in Africa, ed. Susan Arndt, Eckhard Breitinger, and Marek Spitczok von Brisinski (2009) (0)
African Theatre 11: festivals by James Gibbs (ed.) (review) (2013) (0)
Images of yesteryear : filmmaking in Central Africa, Louis Nell : book review (2002) (0)
Contrasting Russian and Chinese perspectives on the future of Asia (1994) (0)
Nya Vägar: Report on the Nya Vägar Seminars on "Striving -- Jihad -- against social exclusion: New Ways of tackling discrimination through co-operation among Christians, Muslims, and other organisations" (2007) (0)
The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). (2022) (0)
Playing the tyrant away: Creative academic resistance to dictatorship in Malawi (2012) (0)
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome (2022) (0)
Popular Culture in Eastern Africa: Archives of the Everyday (2021) (0)
Book review:Biodun Jeyifo: The Yoruba popular travelling theatre or Nigeria Lagos: Nigerian Magazines Publications, 1984 (1990) (0)
Murdering the soul: Representing rape and the commodification of children in Botswana (2015) (0)
Adjuvant chemotherapy (2000) (0)
Phase I and Pharmacokinetic Study of Flavone Acetic Acid 1 (2006) (0)
NGOs, performance and conflict transformation (2005) (0)
Guoguang Wu and Helen Lansdowne (eds.): China Turns to Multilateralism: Foreign Policy and Regional Security (2007) (0)
Hepatic artery chemotherapy and colorectal liver metastases - Reply (2003) (0)
Understanding the constructions of identities by young new Europeans: kaleidoscopic selves. By Alistair Ross (2016) (0)
JAMES GIBBS (ed.), African Theatre 11: festivals. James Currey, Oxford (pb £18.99 – 978 1 84701 057 5). 2012, 172 pp. (2013) (0)
Maronites and Missionaries: a critical appraisal of the affair of As’ad al-Shidyâq (1825-1829) (2003) (0)
The Unity and Variety of Islam (2019) (0)
Warringah Council's experiences with the Sri Lankan Exchange Program (2009) (0)
6082 POSTER Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage l-ll Colon Cancer Patients (2011) (0)
The 1990s have seen a resurgence of interest in citizenship education in the UK and Ireland. Within the UK, interest in citizenship education has been fuelled by (2002) (0)
Software to detect collusion in academic institutions (2007) (0)
Contemporary China: The Dynamics of Change at the Start of the New Millennium. Edited by P.W. Preston and Ju¨rgen Haacke. [London and New York: RoutledgeCurzon, 2002. ix +360 pp. £60.00. ISBN 0-7007-1637-8.] (2003) (0)
Book Review: Adam Schwatzman (ed): Ten South African Poets and Opening Spaces: An anthology of Contemporary African Women's Writing (2004) (0)
Pauline Teaching on the Order of Creation and the Subordination of Women: Its Implications for Christian Education (1989) (0)
Two errors (2004) (0)
Multi-omics characterization of left-right colorectal cancer. (2021) (0)
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTG. (1993) (0)
LONDON'S GOVERNMENT (1961) (0)
Biomarkers in oncology (2021) (0)
Relationship between Expression of β-Tubulin-III Plus ERCC1 in Advanced Ovarian Cancer and Chemotherapy Sensitivity of Paclitaxel Plus Platin Chemotherapy (2020) (0)
Biomarkers: Biomarkers in Oncology (2015) (0)
Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) (0)
Trends in the Incidence and Mortality of the Most Common Cancers in Iraq (Iraqi Cancer Registry 1999-2019). (2022) (0)
Exploring First-Line Irinotecan / Capecitabine in Colorectal Cancer (2017) (0)
Psychiatric Disorders and Risk of Colorectal Cancer: A UK Biobank Cohort Analysis (2022) (0)
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management (2021) (0)
There are Significant Differences in Copy Number Variation Between Microsatellite-Stable and Instable Cases in Stage II/III Colorectal Cancer (2013) (0)
Genome-wide asociation study and meta-analysis in Northrn European populations replicate multiple colorectal cancer risk (2017) (0)
The Essentials of Multiomics (2022) (0)
Colorectal Cancer Second Edition (0)
Appendix A Finding Out About Clinical Trials that are Currently or Soon to be Recruiting (2006) (0)
Genome-wide association study for germline prognostic markers in colorectal cancer. (2010) (0)
Hepatic artery chemotherapy and colorectal liver metastases (2003) (0)

This paper list is powered by the following services:

Other Resources About David Kerr

en.wikipedia.org

What Schools Are Affiliated With David Kerr ?

David Kerr is affiliated with the following schools:

David Kerr 's Academic­Influence.com Rankings

David Kerr 's Degrees

Why Is David Kerr Influential?

David Kerr 's Published Works

Published Works

Other Resources About David Kerr

What Schools Are Affiliated With David Kerr ?

David Kerr 's AcademicInfluence.com Rankings